Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric Ebola Eye Disease in the PREVAIL (Partnership for Research on Ebola Virus in Liberia) III Longitudinal Cohort Study.

Ophthalmology science·2026
Same author

Unplanned Return to the Operating Room After Keratoplasty.

Cornea·2026
Same author

Intraoperative Peripheral Iridotomy for Endothelial Keratoplasty with a 22-Gauge Needle.

Eye banking and corneal transplantation·2026
Same author

Descemet Membrane Endothelial Keratoplasty in an eye with 33mm axial length.

Eye banking and corneal transplantation·2025
Same author

Feasibility of Descemet membrane endothelial keratoplasty with preloaded and trifolded graft after 96-hour storage and shipping.

Eye banking and corneal transplantation·2025
Same author

Declaration of a Pandemic, 5 Years Later-Lessons Learned.

JAMA ophthalmology·2025
Same journal

Approval of retinal gene therapies in the US and Europe based on visual acuity and microperimetry.

Expert review of ophthalmology·2025
Same journal

Infectious etiologies of conjunctival tumors.

Expert review of ophthalmology·2025
Same journal

What will the future role for large language models (LLMs) be in managing patients with glaucoma?

Expert review of ophthalmology·2025
Same journal

Clinical, molecular, and immunologic mechanisms of CMV retinitis: Evolving understanding in HIV and non-HIV immunosuppressed patients.

Expert review of ophthalmology·2025
Same journal

Systemic and Ocular Associations of Keratoconus.

Expert review of ophthalmology·2024
Same journal

How Genome-Wide Association Studies Transform Care for Patients at Risk of Glaucoma.

Expert review of ophthalmology·2024
See all related articles

Related Experiment Video

Updated: Jun 11, 2026

A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
12:36

A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1

Published on: July 22, 2022

Fuchs' corneal dystrophy.

Allen O Eghrari1, John D Gottsch

  • 1Cataract, Cornea and External Disease Service, Wilmer Eye Institute, 600 North Wolfe Street, 317 Maumenee Building, Baltimore, MD 21287, USA.

Expert Review of Ophthalmology
|July 14, 2010
PubMed
Summary
This summary is machine-generated.

Fuchs' corneal dystrophy (FCD) is an inherited eye disease causing blurry vision. Advances in genetics, imaging, and surgery offer new hope for treating this progressive corneal condition.

More Related Videos

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
04:48

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

A Method for Lineage Tracing of Corneal Cells Using Multi-color Fluorescent Reporter Mice
07:48

A Method for Lineage Tracing of Corneal Cells Using Multi-color Fluorescent Reporter Mice

Published on: December 18, 2015

Related Experiment Videos

Last Updated: Jun 11, 2026

A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
12:36

A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1

Published on: July 22, 2022

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
04:48

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

A Method for Lineage Tracing of Corneal Cells Using Multi-color Fluorescent Reporter Mice
07:48

A Method for Lineage Tracing of Corneal Cells Using Multi-color Fluorescent Reporter Mice

Published on: December 18, 2015

Area of Science:

  • Ophthalmology
  • Genetics
  • Corneal Diseases

Background:

  • Fuchs' corneal dystrophy (FCD) is a hereditary, progressive eye condition.
  • It affects the cornea's posterior layers, leading to characteristic guttae and endothelial cell loss.
  • Symptoms include blurry morning vision, worsening over time, and potentially corneal edema and bullae in advanced stages.

Purpose of the Study:

  • To summarize recent advancements in understanding and treating Fuchs' corneal dystrophy.
  • To highlight new opportunities for improving patient outcomes.

Main Methods:

  • Review of current research on FCD genetics and pathophysiology.
  • Analysis of new diagnostic imaging techniques.
  • Evaluation of minimally invasive surgical approaches.

Main Results:

  • Significant progress in identifying genetic factors contributing to FCD.
  • Development of advanced imaging for early detection and monitoring.
  • Emergence of less invasive surgical options offering better patient recovery.

Conclusions:

  • Improved understanding of FCD mechanisms is driving therapeutic innovation.
  • New diagnostic and surgical tools enhance the potential for better management and outcomes.
  • Continued research promises further improvements for patients with this corneal dystrophy.